Avacta Group Plc. is a Biotherapeutics company that offers reagents and therapeutics based on a proprietary Affirmer technology. Headquartered in Wetherby, the United Kingdom, the company was incorporated in 2003.
The biotherapeutics company operates under two segments of Life Sciences and Animal Health. The company seeks to provide scientists with high quality, powerful, and unique tools for coming up with the diagnosis and treatment of humans and animals.
Affirmer technology is the company’s revolutionary technology that seeks to address some of the shortcomings of antibodies. The technology is designed to release active drugs only in the tumors, consequently limiting systematic exposure. The Biotherapeutics Company has also established drug development partnerships with the likes of Moderna Therapeutics ad LG Chem
The stock is currently listed on the London Stock Exchange.